-
TIL Therapy Amplifies the Immune System’s Attack on MelanomaThe recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Q&A
A Musical Takes on CancerMusician and breast cancer survivor Marcy Marxer reenacts life during cancer treatment, with a comedic twist.
by Tyler Santora
-
Facts and Stats
Breast Cancer Survival Rates Continue to RiseNew report highlights decades of progress, as well as a persisting disparity.
by Thomas Celona
-
Survivor Profile
An Inspiration to OthersKay Kays, a 30-year pancreatic cancer survivor, works to advance research and raise awareness of the disease.
by Lindsey Konkel Neabore
-
Forward Look
Immunotherapy for Early-stage Lung CancerImmune checkpoint inhibitors can reduce the risk of recurrence for early-stage non-small cell lung cancer, but researchers are still exploring optimal timing for patients who have surgery.
by Anna Napolitano
-
Forward Look
The Late Effects of Childhood CancerAlmost all childhood cancer survivors will develop significant health problems related to their treatment by age 45.
by Suzanne McBride
-
Forward Look
AI Tool Could Improve Brain Tumor SurgeryAn advanced artificial intelligence tool helps surgeons accurately diagnose pediatric brain tumors during surgery.
by Carolyn Bernhardt
-
Forward Look
Non-surgical Options in Bladder CancerSome people with muscle-invasive cancer can forgo bladder removal surgery.
by Darcy Lewis
-
From the Editor-in-Chief
Early-onset Colorectal Cancer on the RiseResearchers search for reasons for the growing number of cases in people under 50.
by William G. Nelson, MD, PhD
-
Empowering Pediatric Cancer PatientsAfter twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
